Description
Sexually transmitted infections (STIs) are particularly concerned about AMR because of the widespread resistance to most medicines used to treat Neisseria gonorrhoeae in many parts of the world. Other STI pathogens with potential AMR include Mycoplasma genitalium and Trichomonas vaginalis. The department of Global HIV, Hepatitis and STIs Programmes at WHO will participate in the global annual awareness campaign to raise global awareness and understanding on AMR, an important example of One Health collaboration. This year, the departments of AMR and HIV/STIs will organize a joint webinar to launch and discuss 2 WHO Technical products, that are under the Enhanced Gonococcal AMR Surveillance Programme (EGASP) umbrella. It will also be a great opportunity to bring experts, country experience, surveillance data, diagnostics and therapeutics interventions in the pipeline together in one webinar.Comments
Rate This Webinar
Publisher
The World Health Organization (WHO) is a global organization that focuses on promoting health, preventing diseases, and providing healthcare services to all countries. They work in collaboration with member countries and other partners to address health challenges and improve the well-being of people worldwide. WHO provides support and guidance on various health topics, conducts research, and advocates for policies that promote health equity and universal access to quality healthcare. They also play a crucial role in emergency response and preparedness, helping countries to prevent, detect, and respond to outbreaks and other health emergencies.